Keywords: celgene, reports, initial, figures, drugmaker, forecast, revenue

Celgene reports initial 2008 figures

Article | 26 January 2009

Print This

US drugmaker Celgene has forecast total revenue for 2008 of around $2.23 billion, due to rocketing sales of its oncology drug Revlimid ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in